Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Can minors truly consent to reversible puberty blockers in gender-affirming health care?

Logan Vayder
Conditions
July 17, 2023
Share
Tweet
Share

Gender-affirming health care (GAH) is a rapidly developing sector within the medical profession that can include indirect therapies such as counseling, direct therapies such as hormone treatments, puberty blockers, or gender-affirming surgeries. A main ethical concern with GAH resides in its use on adolescents, and this paper will primarily explore the use of puberty blockers, sometimes called GnRH analogues, on minors.

Considering that most children start puberty around the age of 10 or 11, the age at which puberty blockers can be used for the greatest effect is almost always before the age of assent in minors (around age 15). Legal access differs widely between states, with some states not allowing the prescription of puberty blockers to anyone under 18, but guidelines from the World Professional Association for Transgender Health (WPATH) suggest the use of puberty blockers much earlier, as early as age nine in individuals who have attained Tanner Stage II. This raises the ethical question of whether minors can assent to and receive non-invasive puberty blockers.

This essay will consider the safety of puberty blockers in an examination of the common claim that they are fully reversible. This paper may not apply to all youth who are considering undergoing GAH, and special consideration for each individual will continue to be paramount for doctors who prescribe GAH to minors.

The Mayo Clinic guidelines for gender-diverse persons interested in starting puberty blockers state that “GnRH analogues don’t cause permanent physical changes. Instead, they pause puberty.” In the same section, a further claim is made: “When a person stops taking GnRH analogues, puberty starts again.” Similarly, the WPATH Standards of Care for the Health of Transsexual, Transgender, and Gender Nonconforming People lists “the use of GnRH analogues to suppress estrogen or testosterone production and consequently delay the physical changes of puberty” as “fully reversible interventions.” However, a general lack of evidence creates concerns about the certainty of these claims.

A 2017 essay on treating gender dysphoria concluded that “the evidence for the safety and efficacy of puberty suppression is thin, based more on the subjective judgments of clinicians than on rigorous empirical evidence.” While this paper is over six years old, the disturbing lack of evidence for the full reversibility of puberty blockers still permeates discussions today. Instead of new evidence quelling fears, three years ago the National Health Service (NHS) of England changed its statement on puberty blockers from endorsing their full reversibility to now claiming that “little is known about the long-term side effects of hormone or puberty blockers in children with gender dysphoria.” Notably, concerns with the development of brain tissue, bone growth, and psychological effects challenge the reversibility of puberty blockers prescribed to treat gender dysphoria. Despite claims of high certainty in the reversibility of puberty blockers, there is scant evidence that supports the nature of puberty blockers as fully reversible while more and more studies surface claiming the opposite.

The intentionality behind using puberty blockers to treat gender dysphoria greatly differs from the purpose for which puberty blockers were invented, which was to treat precocious puberty in children. Because of this difference, cases arise where puberty blockers are used outside their intended field and may therefore have unknown consequences. This is often the case when puberty blockers are used to treat gender dysphoria.

The fact that children with suppressed precocious puberty between ages 8 and 12 resume puberty at age 13 does not mean that adolescents suffering from gender dysphoria, whose puberty is suppressed beginning at age 12, will simply resume normal pubertal development down the road if they choose to withdraw from the puberty-suppressing treatment…

The use of puberty blockers to treat gender dysphoria remains a highly experimental field with little research to provide adequate justification for their widespread use. Claims of the full reversibility of puberty blockers should be taken with hesitation, considering that they are often the result of biased speculation. Until further research is undertaken to determine the safety of using puberty blockers to treat gender dysmorphia, the risk of wantonly disrupting the natural processes of the human body far outweighs the potential mental health benefits to those struggling with gender dysphoria.

Logan Vayder is a medical ethics student.

Prev

Is obesity really a disease?

July 17, 2023 Kevin 1
…
Next

5 tips for ending office visits on time

July 17, 2023 Kevin 0
…

Tagged as: Pediatrics

Post navigation

< Previous Post
Is obesity really a disease?
Next Post >
5 tips for ending office visits on time

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

Related Posts

  • Are negative news cycles and social media injurious to our health?

    Rabia Jalal, MD
  • The rise of gender reveals: a global health perspective

    Steven G. Duncan
  • How social media can help or hurt your health care career

    Health eCareers
  • Sharing mental health issues on social media

    Tarena Lofton
  • 3 ways to advance the credibility of online health information

    Robert Pearl, MD
  • The gender imbalance in nursing

    Cole Edmonson, DNP and Paulette Anest, RN

More in Conditions

  • How collaboration saved my life from a rare disease doctors couldn’t diagnose

    Tami Burdick
  • Why your emotions are your greatest compass in therapy and life

    Maire Daugharty, MD
  • Patients are not waiting: What MCDA twin parents teach us about shared decision-making

    Stephanie Ernst
  • Health workers deserve care too: How to protect their mental health

    Corey Feist, JD, MBA & Kim Downey, PT
  • Why the words doctors use matter more than they think

    Erin Paterson
  • How AI helped me reclaim my creative mind with ADHD

    Risa Schulman, MD
  • Most Popular

  • Past Week

    • A world without antidepressants: What could possibly go wrong?

      Tomi Mitchell, MD | Meds
    • Why no medical malpractice firm responded to my scientific protocol

      Howard Smith, MD | Physician
    • Navigating physician non-competes: a strategy for staying put [PODCAST]

      The Podcast by KevinMD | Podcast
    • When doctors die in silence: Confronting the epidemic of violence against physicians

      Muhamad Aly Rifai, MD | Physician
    • Doctors speak out: Why we’re saying no to burnout

      Aisha Quarles, MD | Physician
    • Avoiding leadership pitfalls: strategies for success in health care [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • Internal Medicine 2025: inspiration at the annual meeting

      American College of Physicians | Physician
    • What happened to real care in health care?

      Christopher H. Foster, PhD, MPA | Policy
    • The silent crisis hurting pain patients and their doctors

      Kayvan Haddadan, MD | Physician
    • How to build a culture where physicians feel valued [PODCAST]

      The Podcast by KevinMD | Podcast
    • How the CDC’s opioid rules created a crisis for chronic pain patients

      Charles LeBaron, MD | Conditions
    • Are quotas a solution to physician shortages?

      Jacob Murphy | Education
  • Recent Posts

    • Navigating physician non-competes: a strategy for staying put [PODCAST]

      The Podcast by KevinMD | Podcast
    • In the absence of physician mentorship, who will train the next generation of primary care clinicians?

      Kenneth Botelho, DMSc, PA-C | Education
    • Fear of other people’s opinions nearly killed me. Here’s what freed me.

      Jillian Rigert, MD, DMD | Physician
    • What independent and locum tenens doctors need to know about fair market value

      Dennis Hursh, Esq | Physician
    • Health care’s data problem: the real obstacle to AI success

      Jay Anders, MD | Tech
    • What ChatGPT’s tone reveals about our cultural values

      Jenny Shields, PhD | Tech

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 15 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • A world without antidepressants: What could possibly go wrong?

      Tomi Mitchell, MD | Meds
    • Why no medical malpractice firm responded to my scientific protocol

      Howard Smith, MD | Physician
    • Navigating physician non-competes: a strategy for staying put [PODCAST]

      The Podcast by KevinMD | Podcast
    • When doctors die in silence: Confronting the epidemic of violence against physicians

      Muhamad Aly Rifai, MD | Physician
    • Doctors speak out: Why we’re saying no to burnout

      Aisha Quarles, MD | Physician
    • Avoiding leadership pitfalls: strategies for success in health care [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • Internal Medicine 2025: inspiration at the annual meeting

      American College of Physicians | Physician
    • What happened to real care in health care?

      Christopher H. Foster, PhD, MPA | Policy
    • The silent crisis hurting pain patients and their doctors

      Kayvan Haddadan, MD | Physician
    • How to build a culture where physicians feel valued [PODCAST]

      The Podcast by KevinMD | Podcast
    • How the CDC’s opioid rules created a crisis for chronic pain patients

      Charles LeBaron, MD | Conditions
    • Are quotas a solution to physician shortages?

      Jacob Murphy | Education
  • Recent Posts

    • Navigating physician non-competes: a strategy for staying put [PODCAST]

      The Podcast by KevinMD | Podcast
    • In the absence of physician mentorship, who will train the next generation of primary care clinicians?

      Kenneth Botelho, DMSc, PA-C | Education
    • Fear of other people’s opinions nearly killed me. Here’s what freed me.

      Jillian Rigert, MD, DMD | Physician
    • What independent and locum tenens doctors need to know about fair market value

      Dennis Hursh, Esq | Physician
    • Health care’s data problem: the real obstacle to AI success

      Jay Anders, MD | Tech
    • What ChatGPT’s tone reveals about our cultural values

      Jenny Shields, PhD | Tech

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Can minors truly consent to reversible puberty blockers in gender-affirming health care?
15 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...